Overexpression of calreticulin contributes to the development and progression of pancreatic cancer.
about
Endoplasmic reticulum chaperones and oxidoreductases: critical regulators of tumor cell survival and immunorecognitionDNA vaccine encoding human papillomavirus antigens flanked by a signal peptide and a KDEL sequence induces a potent therapeutic antitumor effect.Calreticulin is a novel independent prognostic factor for oral squamous cell carcinomaIdentification of chemoresistant factors by protein expression analysis with iTRAQ for head and neck carcinoma.Calreticulin down-regulation inhibits the cell growth, invasion and cell cycle progression of human hepatocellular carcinoma cells.The Histone Deacetylase Inhibitor BML-210 Influences Gene and Protein Expression in Human Promyelocytic Leukemia NB4 Cells via Epigenetic Reprogramming.Ex vivo tracing of pancreatic neuroendocrine tumors with bio-conjugated fluorescent quantum dots: a paradigm of nanoparticle-based diagnosticsCalreticulin is highly expressed in pancreatic cancer stem-like cells.Coexistence of JAK2 and CALR mutations and their clinical implications in patients with essential thrombocythemia.Musashi2 promotes the development and progression of pancreatic cancer by down-regulating Numb protein.Role of Nerve Growth Factor (NGF) and miRNAs in Epithelial Ovarian Cancer.Comparative proteomics-network analysis of proteins responsible for ursolic acid-induced cytotoxicity in colorectal cancer cells.Calreticulin, a therapeutic target?Expression of vitamin D receptor as a potential prognostic factor and therapeutic target in pancreatic cancer.Honokiol confers immunogenicity by dictating calreticulin exposure, activating ER stress and inhibiting epithelial-to-mesenchymal transition.Functional roles of calreticulin in cancer biology.Up-regulation of calreticulin in mouse liver tissues after long-term irradiation with low-dose-rate gamma rays.Calreticulin promotes EGF-induced EMT in pancreatic cancer cells via Integrin/EGFR-ERK/MAPK signaling pathway.Therapeutic DNA Vaccines for Human Papillomavirus and Associated Diseases.Expression and significance of calreticulin in human osteosarcoma.Identification of PGAM1 as a putative therapeutic target for pancreatic ductal adenocarcinoma metastasis using quantitative proteomics.
P2860
Q26823628-5664106E-83CA-488B-9454-879C10D99055Q33598307-DC9C55D7-0293-4BA4-9B05-0F6791809510Q33751020-62B042D0-0E66-4E15-9D64-CAE325091034Q34052005-8B2FE087-8E14-4571-AE05-4150F99BC413Q35996901-7B69309F-D91C-4949-926A-106B06880643Q36088554-8ABD89F6-237A-4C11-AD23-E6ADF7596FC0Q36098538-9F1DEF7B-0690-4B66-AC0F-11FBFF37A203Q37462512-D63B5BDA-FE3D-4B98-B195-5640185F5BE5Q37636747-80F2E3EE-B64C-43CA-8805-A1631E80C440Q37716372-61D4204D-2FC2-4C71-89BE-30171B202E6DQ37729033-BC74CCB7-3935-44CD-ABA0-284E423C607CQ38710255-8D618C85-6236-40D9-B458-EDA0C33A05F3Q38766974-B94F63EA-1313-412A-AEB5-CD5195801410Q38914179-A02EF257-2D65-402F-99C5-A763A3E3BDEEQ38916710-26F099FF-B043-48C2-9609-A6AA923F120FQ39607843-45783D21-3753-4459-9B07-FF8A94D145D8Q41941309-2639820F-2759-4265-9A38-4F823952B26EQ47127885-DC1C8097-3A49-49FF-8816-0F28D9259203Q50115667-301A73BC-DCF3-4A3B-A177-66D1AEFEB9EFQ51179296-9E6F30F0-CC5A-4F18-8B17-79DE512F442DQ55252749-34546C97-946E-4BAA-98ED-1B09D2C0B9FD
P2860
Overexpression of calreticulin contributes to the development and progression of pancreatic cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Overexpression of calreticulin ...... gression of pancreatic cancer.
@en
Overexpression of calreticulin ...... gression of pancreatic cancer.
@nl
type
label
Overexpression of calreticulin ...... gression of pancreatic cancer.
@en
Overexpression of calreticulin ...... gression of pancreatic cancer.
@nl
prefLabel
Overexpression of calreticulin ...... gression of pancreatic cancer.
@en
Overexpression of calreticulin ...... gression of pancreatic cancer.
@nl
P2093
P2860
P356
P1476
Overexpression of calreticulin ...... gression of pancreatic cancer.
@en
P2093
Chuanping Chen
Jianping Zhou
Qingfeng Liu
Weiwei Sheng
P2860
P304
P356
10.1002/JCP.24519
P577
2014-07-01T00:00:00Z